Puzzles in the clinical pharmacokinetics of fluorouracil.

Desoize, B; Bouche, O; Berthiot, G; Coninx, P

Desoize, B; Bouche, O; Berthiot, G; Coninx, P.

Affiliation

Desoize B; IFR53-EA2063, Laboratoire de Biochimie, Reims, France. bernard.desoize@univ-reims.fr

Anticancer Res ; 18(6B): 4607-10, 1998.

Article in En | MEDLINE | ID: mdl-9891526

Subject(s)

Antimetabolites, Antineoplastic/pharmacokinetics; Carcinoma, Non-Small-Cell Lung/drug therapy; Colonic Neoplasms/drug therapy; Fluorouracil/pharmacokinetics; Lung Neoplasms/drug therapy; Antimetabolites, Antineoplastic/administration & dosage; Antimetabolites, Antineoplastic/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Non-Small-Cell Lung/blood; Cisplatin/administration & dosage; Colonic Neoplasms/blood; Drug Administration Schedule; Fluorouracil/administration & dosage; Fluorouracil/therapeutic use; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Leucovorin/therapeutic use; Lung Neoplasms/blood; Time Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms / Carcinoma, Non-Small-Cell Lung / Fluorouracil / Lung Neoplasms / Antimetabolites, Antineoplastic Limits: Humans Language: En Journal: Anticancer Res Year: 1998 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links